FN1 and neoplasm: The difference in the scheme of the Fn-infected model is as follows: in the previous study, Fn was persistently intratumorally injected every 3 days after the tumor volume reached ~100 mm3, whereas in our study, we only injected Fn three times by tail vein before subcutaneous injection of tumor cells.